Clinically, routine metabolic screening in MDD could guide precision treatments targeting insulin pathways, particularly in those with metabolic dysfunction, and future studies considering the role of insulin, especially in those with insulin resistance, may enable development of novel therapeutics.
K. Palacek, O. Corbeil, Saguna Katyal et al.· Frontiers in Psychiatry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.